What Is the World to Do About Gene-Editing?
By Stephen Buranyi,
The New York Review of Books
| 03. 21. 2019
When the journal Science chose the radical gene-editing technology CRISPR as its 2015 breakthrough of the year, the editorial team closed its description on a dire note. “For better or worse, we all now live in CRISPR’s world,” they wrote. Emerging into the public consciousness in 2013, CRISPR has been with us only as long as it takes to complete secondary school, but like the information technologies that rose alongside it, it is often described as if it is beyond regulation and direction, as if it had acquired its own uncompromising telos.
CRISPR works by repurposing parts of an ancient bacterial immune system to make the job of editing genes in almost any organism unprecedentedly simple and accurate. So simple, in fact, that unlike other scientific advancements that are perpetually just around the corner, CRISPR entered widespread use almost immediately. Gene-edited mice and zebrafish, classic laboratory models, rapidly gave way to edits in the genomes of livestock such as pigs and cows. Chinese scientists have been running human gene-editing trials since 2016, and the first stateside trials for CRISPR in...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...